![Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism - Journal of the American Academy of Child & Adolescent Psychiatry Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/524e116a-843a-4b14-9956-e4235d32ed12/gr1.gif)
Multisite, Double-Blind, Placebo-Controlled Trial of Porcine Secretin in Autism - Journal of the American Academy of Child & Adolescent Psychiatry
![Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study | Nature Medicine Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01861-9/MediaObjects/41591_2022_1861_Fig1_HTML.png)
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study | Nature Medicine
![A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE LIVER-SELECTIVE TR-BETA AGONIST VK2809 (MB07811) IN HYPERCHOLESTEROLEMIC SUBJECTS | Journal of the ... A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE LIVER-SELECTIVE TR-BETA AGONIST VK2809 (MB07811) IN HYPERCHOLESTEROLEMIC SUBJECTS | Journal of the ...](https://www.jacc.org/cms/asset/d1965ee9-a801-43e8-9f94-597f41cfd745/s0735-1097(16)31933-7.fp.png)
A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE LIVER-SELECTIVE TR-BETA AGONIST VK2809 (MB07811) IN HYPERCHOLESTEROLEMIC SUBJECTS | Journal of the ...
A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers | PLOS ONE
![A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma: Molecular Therapy A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma: Molecular Therapy](https://www.cell.com/cms/attachment/0a485821-36b7-4524-8968-7934f46cbd69/gr1_lrg.jpg)
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma: Molecular Therapy
![A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820300260-fx1.jpg)
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome - ScienceDirect
![Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial - Clinical Nutrition ESPEN Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial - Clinical Nutrition ESPEN](https://clinicalnutritionespen.com/cms/asset/4a7610d2-fe20-4458-9a7f-30db7b637a6e/gr1.jpg)
Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial - Clinical Nutrition ESPEN
![Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/49f40097-6e0d-4932-85b8-0be2c505a647/gr1.gif)
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet
![Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial | The BMJ Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial | The BMJ](https://www.bmj.com/content/bmj/320/7245/1297/F1.large.jpg)
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial | The BMJ
![Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | Scientific Reports Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-42059-3/MediaObjects/41598_2019_42059_Fig1_HTML.png)
Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease | Scientific Reports
![Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice](https://www.endocrinepractice.org/cms/asset/f9b016fe-bd8d-4a93-a587-d4f33837b0e9/gr1.jpg)
Randomized, Double-Blind, Placebo-Controlled Trial of Orlistat for Weight Loss in Adolescents - Endocrine Practice
![A Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy | Journal of Clinical Sleep Medicine A Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy | Journal of Clinical Sleep Medicine](https://jcsm.aasm.org/cms/asset/d2ee67f3-7b4c-4555-8d80-1e76b14bcf41/jcsm.26368.fp.png)
A Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy | Journal of Clinical Sleep Medicine
![Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD - Journal of the American Academy of Child & Adolescent Psychiatry Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/907a6e50-7a6f-444b-b0ba-e7b205aeed8a/gr1.gif)
Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD - Journal of the American Academy of Child & Adolescent Psychiatry
![A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/cf5e8046-e618-48ed-873e-1879d97e4e5c/gr1.jpg)
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19 - eClinicalMedicine
![A randomised, double-blind, placebo-controlled, 39 week trial of ITCA 650 as add-on therapy in type 2 diabetes - Media Centre | EASD A randomised, double-blind, placebo-controlled, 39 week trial of ITCA 650 as add-on therapy in type 2 diabetes - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/624_783118_1/Slide1.jpg)
A randomised, double-blind, placebo-controlled, 39 week trial of ITCA 650 as add-on therapy in type 2 diabetes - Media Centre | EASD
Randomized, double-blind, placebo-controlled clinical trial flow. The... | Download Scientific Diagram
![Nutrients | Free Full-Text | Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo- Controlled Trial Nutrients | Free Full-Text | Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo- Controlled Trial](https://www.mdpi.com/nutrients/nutrients-14-03048/article_deploy/html/images/nutrients-14-03048-g001.png)
Nutrients | Free Full-Text | Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo- Controlled Trial
![Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | Full Text Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-019-0038-9/MediaObjects/42466_2019_38_Fig2_HTML.png)
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | Full Text
![A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2bfdc746-00e2-4fee-9d59-44bd08d85bd9/gr1.jpg)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation - Biology of Blood and Marrow Transplantation
![A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned - MedWorks Media A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned - MedWorks Media](https://medworksmedia.com/wp-content/uploads/2017/10/Cover-2-5-2.png)